Bolt Biotherapeutics (BOLT) Revenue (2020 - 2026)
Bolt Biotherapeutics (BOLT) posted Revenue of $26000.0 for Q1 2026, down 98.96% sequentially from $2.5 million in Q4 2025, and down 97.87% YoY from $1.2 million in Q1 2025.
Bolt Biotherapeutics (BOLT) Revenue (2020 - 2026) Analysis & Trends
Bolt Biotherapeutics has reported Revenue for 7 years, with the latest figure at $26000.0 in Q1 2026.
- Quarterly Revenue fell 97.87% year-over-year to $26000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.5 million (up 78.64% YoY) and the FY2025 annual result came in at $7.7 million, changed 0.07% from the prior year.
- Revenue declined to $26000.0 in Q1 2026 per BOLT's latest filing, from $2.5 million in the prior quarter.
- Over five years, Revenue peaked at $5.3 million in Q1 2024 and troughed at $26000.0 in Q1 2026.
- A 5-year average of $1.8 million and a median of $1.6 million in 2023 frame the typical range for Revenue.
- The sharpest annual moves came in 2024 and 2026: Revenue surged 188.83% in 2024, then plunged 97.87% in 2026.
- Over 5 years, Revenue stood at $1.4 million in 2022, then soared by 48.05% to $2.1 million in 2023, then tumbled by 45.38% to $1.1 million in 2024, then surged by 119.11% to $2.5 million in 2025, then sank by 98.96% to $26000.0 in 2026.
- According to Business Quant data, Revenue over the past three periods registered $26000.0, $2.5 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Bolt Biotherapeutics | 5.48 Mn | 5.48 Mn | - | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5,000.00 |
| Mar 31, 2026 | 26,000.00 |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | 1.80 Mn |
| Mar 31, 2025 | 1.22 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 5.27 Mn |
| Dec 31, 2023 | 2.09 Mn |
| Sep 30, 2023 | 2.53 Mn |
| Jun 30, 2023 | 1.43 Mn |
| Mar 31, 2023 | 1.83 Mn |
| Dec 31, 2022 | 1.41 Mn |
| Sep 30, 2022 | 2.11 Mn |
| Jun 30, 2022 | 1.39 Mn |
| Mar 31, 2022 | 813,000.00 |
| Dec 31, 2021 | 508,000.00 |
| Sep 30, 2021 | 752,000.00 |
| Jun 30, 2020 | 67,000.00 |